微泰医疗器械（杭州）股份有限公司（02235）于2026年2月9日公告，披露翌日披露报表显示公司于同日回购股份合计26,000股，占回购前已发行股份约0.0157%。本次回购的价格范围为每股7.26港元至7.33港元，涉资约19万港元。回购完成后，公司已发行股份数目变动为165,743,042股，库藏股增至3,432,800股。
据公告介绍，购回授权决议通过日期为2025年5月28日，公司尚可根据授权购回16,668,364股。公司确认回购程序遵循香港联交所上市规则及相关法律法规。
公告由执行董事及联席公司秘书施永辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.